Covered recipient · General Payments record
DEIRDRE J COHEN
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$38,029.13
- Reported across 43 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $3,225.00 | 2 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,975.00 | 1 |
| Honoraria | $2,400.00 | 1 |
| Travel and Lodging | $742.06 | 2 |
| Food and Beverage | $306.56 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $3,771.47 | 3 |
| Fosun Pharma USA Inc. | $2,587.29 | 2 |
| Eli Lilly and Company | $1,664.86 | 2 |
| BeiGene USA, Inc. | $1,625.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $119.27 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139379906 | CMS |
| Astellas Pharma US Inc | $677.20 | 05/16/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139387660 | CMS |
| Astellas Pharma US Inc | $2,975.00 | 05/16/2024 | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Undisputed | 01/23/2026 | 1139387662 | CMS |
| BeiGene USA, Inc. | $1,625.00 | 11/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120854753 | CMS |
| Eli Lilly and Company | $1,600.00 | 05/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1136148648 | CMS |
| Eli Lilly and Company | $64.86 | 05/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1136165362 | CMS |
| Fosun Pharma USA Inc. | $187.29 | 06/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146938714 | CMS |
| Fosun Pharma USA Inc. | $2,400.00 | 06/25/2024 | Honoraria | Undisputed | 01/23/2026 | 1146938712 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.